Eficacia de los bifosfonatos en la espondilitis anquilosante

Urine or IL 1 Inhibitor Urine or Urine IL‐1 Inhibitor or IL‐1Ra or Antril or Synergen Brand of
Anakinra or Anakinra Synergen Brand or Kineret or Amgen Brand of Anakinra or Anakinra
Amgen Brand or Anakinra or Amtril or l 1ra or Interleukin 1 Antagonist or Interleukin 1ra or
Interleukin 1 or Receptor Antagonist or Interleukin 1 Receptor Antagonist Protein).mp.
[mp=title, abstract, subject headings, heading word, drug trade name, original title, device
manufacturer, drug manufacturer name]
32. 30 or 31 or 29
33. abatacept.mp. or ABATACEPT/
34. (abatacept or belatacept or LEA29Y or BMS‐224818 or BMS‐224818 or ctla‐4‐ig cytotoxic t
lymphocyte associated antigen 4‐ ig or orencia orbis 188667 or orbms‐188667 or Bms 188667
or Bms188667 or Ctla4 Ig or Ctla4ig or Ctla4 Immunoglobulin or Ctla4 Immunoglobulin G or
Orencia).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original
title, device manufacturer, drug manufacturer name]
35. abatacept.af.
36. 35 or 33 or 34
37. Cyclophosphamide.af.
38. CYCLOPHOSPHAMIDE DERIVATIVE/ or CYCLOPHOSPHAMIDE/ or Cyclophosphamide.mp.
39. cyclophosphan OR cyclophosphane OR procyon OR sendoxan OR neosar OR
cyclophosphamide isomer OR cyclophosphamide AND isomer of cyclophosphamide AND (S)
AND isomer OR cytoxan OR endoxan OR cyclophosphamide monohydrate OR monohydrate
cyclophosphamide
40. 38 or 39 or 37
41. Cholrambucil.mp. or Chlorambucil/
42. (Cholrambucil or Chlorambucil).af.
43. ((n, n di and 2‐chloroethyl and p aminophenylbutyric acid chlorbutin or4‐ and (Bis and 2‐
chloroethyl and amino)) or glaxosmithkline brand of chlorambucil or wellcome brand of
chlorambucil or lympholysis or amboclorin or antineoplastic agents alkylating).mp. [mp=title,
abstract, subject headings, heading word, drug trade name, original title, device manufacturer,
drug manufacturer name]
44. 42 or 43 or 41
45. 4 and 24 and 19
46. limit 45 to (human and (english or french or spanish))
47. 46 and 13 talidomia_eficacia_artritispsoriásica
48. 8 and 24 and 19
49. limit 48 to (human and (english or french or spanish))
50. 49 and 13 talidomia_eficacia_espondiloartropatías
51. 24 and 19 and 12
52. 51 and 13
53. limit 52 to (human and (english or french or spanish))
talidomia_eficacia_espondilitisankilosante
54. 4 and 28 and 19